Comparative study of three doses of interferon-alpha 2a in chronic active hepatitis B. The International Hepatitis Trial Group.
about
The role of interferon therapy in hepatitis BPeginterferon-alpha 2a for the treatment of hepatitis B infection.Prevention of hepatitis B virus-associated liver diseases by antiviral therapy.Sustained response to peginterferon alfa-2a (40 kD) with or without lamivudine in Asian patients with HBeAg-positive and HBeAg-negative chronic hepatitis B.[Efficacy of interferon (conventional, pegylated) and lamivudine for treatment of chronic hepatitis B: a systematic review].The long-term effect of treatment with interferon-alpha 2a in chronic hepatitis B. The Long-Term Follow-up Investigator Group. The European Study Group on Viral Hepatitis (EUROHEP). Executive Team on Anti-Viral Treatment.
P2860
Comparative study of three doses of interferon-alpha 2a in chronic active hepatitis B. The International Hepatitis Trial Group.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh
1994年學術文章
@zh-hant
name
Comparative study of three dos ...... ational Hepatitis Trial Group.
@en
Comparative study of three dos ...... ational Hepatitis Trial Group.
@nl
type
label
Comparative study of three dos ...... ational Hepatitis Trial Group.
@en
Comparative study of three dos ...... ational Hepatitis Trial Group.
@nl
prefLabel
Comparative study of three dos ...... ational Hepatitis Trial Group.
@en
Comparative study of three dos ...... ational Hepatitis Trial Group.
@nl
P2093
P2860
P1476
Comparative study of three dos ...... ational Hepatitis Trial Group.
@en
P2093
G Cooksley
G M Dusheiko
H C Thomas
P2860
P304
P356
10.1111/J.1365-2893.1994.TB00113.X
P577
1994-01-01T00:00:00Z